Table 1.
General characteristics and laboratory findings at initial clinical assessment of 184 patients with P. falciparum malaria
| Parameter | Amsterdam (AMC) | Rotterdam (HZH) |
|---|---|---|
| Number of patients, n | 77 | 107 |
| Male/female | 52/25 | 78/29 |
| Age, median (range,) yrs | 37 (0 - 61) | 40 (16 - 70) |
| Purpose of travel | ||
| Immigrant, n (%) | 4 (5.2) | 0 (0.0) |
| Visiting friends and relatives, n (%) | 48 (62.3) | 36 (33.6) |
| Tourist, n (%) | 6 (7.8) | 20 (18.7) |
| Business, n (%) | 10(13.0) | 27 (25.2) |
| Expatriate, n (%) | 0 (0.0) | 4 (3.7) |
| Sailor, n (%) | 0 (0.0) | 4 (3.7) |
| Unknown, n (%) | 9 (11.7) | 11 (10.3) |
| Continent of acquisition | ||
| Africa, n (%) [West-Africa, n (%)] | 73 (94.8) [63 (81.8)] | 101 (94.9) [71 (66.4)] |
| South-America, n (%) | 2 (2.6) | 1 (0.9) |
| South East Asia, n (%) | 2 (2.6) | 7 (6.5) |
| Clinical assessment | ||
| Severe malaria, n (%) | 7 (9.1) | 16 (15.0) |
| Non-severe malaria, n (%) | 70 (90.9) | 91 (85.0) |
| Laboratory findings | ||
| Parasite load, median range, trophozoites/μL | 4648 (50 - 558000) | 10664 (2 - 1380600) |
| Malaria Now | 77 (100) | 107 (100) |
| HRP-2 and aldolase co-reactivity, n (%) | 54 (70.1) | 78 (72.9) |
| HRP-2 reactivity, n (%) | 23 (29.9) | 29 (27.1) |